Back to Archived Journals » Core Evidence

Core Evidence ceased publishing in January 2023. All articles that have been published in Core Evidence will continue to be available on the Dove Press site, and will be securely archived with CLOCKSS.

Journal Articles:

- 143 records -

Riociguat in the Treatment of Chronic Thromboembolic Pulmonary Hypertension: An Evidence-Based Review of Its Place in Therapy

Donaldson S, Ogunti R, Kibreab A, Mehari A

Core Evidence 2020, 15:31-40

Published Date: 25 August 2020

Vedolizumab in the Treatment of Ulcerative Colitis: An Evidence-Based Review of Safety, Efficacy, and Place of Therapy

Takatsu N, Hisabe T, Higashi D, Ueki T, Matsui T

Core Evidence 2020, 15:7-20

Published Date: 1 April 2020

Tedizolid phosphate for the treatment of acute bacterial skin and skin-structure infections: an evidence-based review of its place in therapy

Bassetti M, Castaldo N, Carnelutti A, Peghin M, Giacobbe DR

Core Evidence 2019, 14:31-40

Published Date: 5 July 2019

Lomitapide: a review of its clinical use, efficacy, and tolerability

Alonso R, Cuevas A, Mata P

Core Evidence 2019, 14:19-30

Published Date: 1 July 2019

Eslicarbazepine acetate in the treatment of adults with partial-onset epilepsy: an evidence-based review of efficacy, safety and place in therapy

Lattanzi S, Brigo F, Cagnetti C, Verrotti A, Zaccara G, Silvestrini M

Core Evidence 2018, 13:21-31

Published Date: 8 March 2018

Dupilumab: an evidence-based review of its potential in the treatment of atopic dermatitis

Eshtiaghi P, Gooderham MJ

Core Evidence 2018, 13:13-20

Published Date: 23 February 2018

Canagliflozin in the treatment of type 2 diabetes: an evidence-based review of its place in therapy

Karagiannis T, Bekiari E, Tsapas A

Core Evidence 2017, 12:1-10

Published Date: 15 March 2017

Iloperidone in the treatment of schizophrenia: an evidence-based review of its place in therapy

Tonin FS, Wiens A, Fernandez-Llimos F, Pontarolo R

Core Evidence 2016, 11:49-61

Published Date: 14 December 2016

Imiglucerase in the management of Gaucher disease type 1: an evidence-based review of its place in therapy

Serratrice C, Carballo S, Serratrice J, Stirnemann J

Core Evidence 2016, 11:37-47

Published Date: 14 October 2016

Everolimus in the management of metastatic renal cell carcinoma: an evidence-based review of its place in therapy

Buti S, Leonetti A, Dallatomasina A, Bersanelli M

Core Evidence 2016, 11:23-36

Published Date: 1 September 2016

Pirfenidone in the treatment of idiopathic pulmonary fibrosis: an evidence-based review of its place in therapy

Margaritopoulos GA, Vasarmidi E, Antoniou KM

Core Evidence 2016, 11:11-22

Published Date: 1 July 2016

Clinical utility of tadalafil in the treatment of pulmonary arterial hypertension: an evidence-based review

Henrie AM, Nawarskas JJ, Anderson JR

Core Evidence 2015, 10:99-109

Published Date: 2 November 2015

Nintedanib: evidence for its therapeutic potential in idiopathic pulmonary fibrosis

Inomata M, Nishioka Y, Azuma A

Core Evidence 2015, 10:89-98

Published Date: 27 August 2015

Rasburicase in the management of tumor lysis: an evidence-based review of its place in therapy

Dinnel J, Moore BL, Skiver BM, Bose P

Core Evidence 2015, 10:23-38

Published Date: 13 January 2015

Dulaglutide: an evidence-based review of its potential in the treatment of type 2 diabetes

Edwards KL, Minze MG

Core Evidence 2015, 10:11-21

Published Date: 9 January 2015

Sipuleucel-T in the treatment of prostate cancer: an evidence-based review of its place in therapy

Graff JN, Chamberlain ED

Core Evidence 2015, 10:1-10

Published Date: 18 December 2014

Luliconazole for the treatment of fungal infections: an evidence-based review

Khanna D, Bharti S

Core Evidence 2014, 9:113-124

Published Date: 24 September 2014

Brodalumab: an evidence-based review of its potential in the treatment of moderate-to-severe psoriasis

Coimbra S, Figueiredo A, Santos-Silva A

Core Evidence 2014, 9:89-97

Published Date: 21 July 2014

Clinical utility of treprostinil in the treatment of pulmonary arterial hypertension: an evidence-based review

Buckley MS, Berry AJ, Kazem NH, Patel SA, Librodo PA

Core Evidence 2014, 9:71-80

Published Date: 20 June 2014

Development of cabozantinib for the treatment of prostate cancer [Corrigendum]

Vaishampayan UN

Core Evidence 2014, 9:69-70

Published Date: 16 May 2014

Development of cabozantinib for the treatment of prostate cancer

Vaishampayan UN

Core Evidence 2014, 9:61-67

Published Date: 23 April 2014

Eptifibatide: The evidence for its role in the management of acute coronary syndromes [Corrigendum]

Shah I, Khan SO, Malhotra S, Fischell T

Core Evidence 2014, 9:49-50

Published Date: 14 March 2014

Mavrilimumab: an evidence based review of its potential in the treatment of rheumatoid arthritis

Di Franco M, Gerardi MC, Lucchino B, Conti F

Core Evidence 2014, 9:41-48

Published Date: 12 March 2014

Micafungin: an evidence-based review of its place in therapy

de la Torre P, Reboli AC

Core Evidence 2014, 9:27-39

Published Date: 25 February 2014

Targeted therapy in triple-negative metastatic breast cancer: a systematic review and meta-analysis

Clark O, Botrel TE, Paladini L, Ferreira MB

Core Evidence 2014, 9:1-11

Published Date: 6 January 2014

Sugammadex as a reversal agent for neuromuscular block: an evidence-based review

Schaller SJ, Fink H

Core Evidence 2013, 8:57-67

Published Date: 25 September 2013

Ibrutinib: an evidence-based review of its potential in the treatment of advanced chronic lymphocytic leukemia

Chavez JC, Sahakian E, Pinilla-Ibarz J

Core Evidence 2013, 8:37-45

Published Date: 16 May 2013

Enzalutamide: an evidence-based review of its use in the treatment of prostate cancer

Golshayan AR, Antonarakis ES

Core Evidence 2013, 8:27-35

Published Date: 4 April 2013

More articles